nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women
|
de Almeida, Ada Trindade |
|
|
14 |
8 |
p. 2093-2108 |
artikel |
2 |
Association Between Natural Hair Color, Race, and Alopecia
|
Kamal, Kanika |
|
|
14 |
8 |
p. 2109-2117 |
artikel |
3 |
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
|
Mansilla-Polo, Miguel |
|
|
14 |
8 |
p. 1983-2038 |
artikel |
4 |
Biomarkers in Cutaneous Keratinocyte Carcinomas
|
Montano, Erica |
|
|
14 |
8 |
p. 2039-2058 |
artikel |
5 |
Bridging the Gap: Comparing Patient-Clinician Views on Treatment Goals and Communication in the Management of Atopic Dermatitis Within the Asia–Pacific Region
|
Chu, Chia-Yu |
|
|
14 |
8 |
p. 2195-2208 |
artikel |
6 |
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study
|
Korge, Bernhard |
|
|
14 |
8 |
p. 2077-2092 |
artikel |
7 |
Clinical Characteristics and Disease Burden of Patients with Moderate-to-Severe Generalized Pustular Psoriasis Flares in Taiwan
|
Lu, Chun-Wei |
|
|
14 |
8 |
p. 2261-2275 |
artikel |
8 |
Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
|
Armstrong, April W. |
|
|
14 |
8 |
p. 2297 |
artikel |
9 |
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
|
Armstrong, April W. |
|
|
14 |
8 |
p. 2235-2248 |
artikel |
10 |
Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis
|
McKee, Stephanie |
|
|
14 |
8 |
p. 2127-2138 |
artikel |
11 |
Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs
|
Eichner, Adina |
|
|
14 |
8 |
p. 2153-2169 |
artikel |
12 |
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
|
Torres, Tiago |
|
|
14 |
8 |
p. 2209-2221 |
artikel |
13 |
Hair Shaft Abnormalities as a Dermoscopic Feature of Mycosis Fungoides: Pilot Results
|
Jasińska, Magdalena |
|
|
14 |
8 |
p. 2119-2126 |
artikel |
14 |
How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa
|
Boucher, Annie |
|
|
14 |
8 |
p. 1975-1981 |
artikel |
15 |
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
|
Silverberg, Jonathan I. |
|
|
14 |
8 |
p. 2249-2260 |
artikel |
16 |
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
|
Gooderham, Melinda J. |
|
|
14 |
8 |
p. 2285-2296 |
artikel |
17 |
Psoriasis and Sleep Disturbance: A US Population-Based Study Using the NHANES Database
|
Smith, Payton |
|
|
14 |
8 |
p. 2277-2283 |
artikel |
18 |
Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies
|
Bibeau, Kristen |
|
|
14 |
8 |
p. 2223-2234 |
artikel |
19 |
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
|
Simpson, Eric L. |
|
|
14 |
8 |
p. 2139-2151 |
artikel |
20 |
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks
|
Yosipovitch, Gil |
|
|
14 |
8 |
p. 2171-2180 |
artikel |
21 |
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
|
Soung, Jennifer |
|
|
14 |
8 |
p. 2181-2193 |
artikel |
22 |
Treatment of Epidermolysis Bullosa and Future Directions: A Review
|
Danescu, Sorina |
|
|
14 |
8 |
p. 2059-2075 |
artikel |